Similarly, our antisense targeting gRNAs 11 and 17 successfully reduced the antisense repeat-containing transcripts in all three C9orf72 ALS/FTD iPSC-neuron lines by ~32% and ~73% respectively (Fig. 2d). This evidence concerns the gene C9orf72 and frontotemporal dementia.